<DOC>
	<DOCNO>NCT00163449</DOCNO>
	<brief_summary>The aim present study compare efficacy inhaled ciclesonide pre-school child . Ciclesonide inhale daily , use one three dose level test versus placebo . The study duration consist baseline period ( 2 4 week ) treatment period ( 24 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Safety Ciclesonide Preschool Children With Asthma ( 2 6 Years ) ( BY9010/M1-207 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Written inform consent parent legal guardian patient Outpatients Good health exception asthma Documented diagnosis asthma 6 month Use rescue medication pretreatment controller drug Main Concomitant severe disease Diseases contraindicate use inhaled steroid Other relevant lung disease cause impairment pulmonary function Recurrent , episodic wheeze History lifethreatening asthma History mechanical ventilation Clinically relevant abnormal laboratory value suggest unknown disease require clinical evaluation Premature birth ( &lt; 32 week gestation )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Child</keyword>
	<keyword>Pediatric</keyword>
</DOC>